HB Estate Developers Limited has announced that its board of directors will convene on February 13, 2026, to consider and approve the company's unaudited financial results for the third quarter and nine months ended December 31, 2025. The announcement was made through a formal communication to BSE Limited on February 2, 2026, in compliance with regulatory requirements.

Board Meeting Details

The meeting has been scheduled in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review both standalone and consolidated financial results for the specified period.

Trading Window Closure

In connection with the upcoming financial results announcement, HB Estate Developers Limited has implemented a trading window closure for designated persons and their immediate relatives. This restriction will remain in effect until February 15, 2026, which is 48 hours after the declaration of the unaudited financial results.

The company had previously communicated about this trading window closure in a letter dated December 24, 2025, ensuring compliance with insider trading regulations and maintaining market integrity during the results announcement period.

Regulatory Compliance

The formal intimation was signed by N V K Rao, Company Secretary and Compliance Officer, and submitted to the BSE Limited listing department. HB Estate Developers Limited trades on BSE under company code 532334, and the company maintains its registered office at Plot No. 31, Echelon Institutional Area, Sector-32, Gurugram, Haryana.

HB Estate Developers Limited has received trading approval from BSE Limited for equity shares allotted through preferential allotment. The approval marks a significant milestone in the company's capital structure expansion plans.

Trading Approval Details

The company received trading approval vide letter Ref: LOD/PREF/SV/227/2025-2026 dated December 11, 2025, from BSE Limited. The approval is effective from Friday, December 12, 2025, enabling trading of the preferentially allotted shares.

Share Details and Listing

The 7,50,000 equity shares carry distinctive numbers from 56301869 to 57051868. These shares were issued to Non-Promoters on a preferential basis pursuant to conversion of warrants. BSE Limited has confirmed that the securities are listed on the Exchange effective from the trading commencement date.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The trading approval letter from BSE Limited has been submitted to ensure complete regulatory compliance. The company communicated this development to BSE Limited on December 15, 2025, providing revised intimation of the trading approval receipt.

Previous Capital Structure Changes

This development follows the company's earlier capital structure modifications during the second quarter. The company had previously allotted 750,000 equity shares on July 15, 2025, following the exercise of convertible warrants, which increased the paid-up capital to ₹22,20,99,470. The October 14, 2025 allotment further increased the capital to ₹22,95,99,470.

Market Impact

The trading approval enables liquidity for the preferentially allotted shares and provides flexibility to the allottees. The preferential allotment was part of the company's capital raising initiatives, with shares issued at ₹65.25 per share, representing a premium of ₹55.25 over the face value of ₹10.00 per share.